One more Ebola illness and one more death from the virus have been confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, the World Health Organization (WHO) African regional office said on Twitter today.
The new developments push the outbreak total to 89 cases and 37 deaths.
The southern half of the country continues to report the highest death tolls, which nationally may be higher than thought, based on new excess death estimates.
A case report today in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report describes three cases of multidrug-resistant tuberculosis (MDR-TB) among workers at an Ohio food-processing facility.
About 1 in 15 US parents (6.1%) is hesitant about childhood vaccines, while 1 in 4 (26%) are unsure about flu vaccines.
Twelve cases have now been reported in a new Ebola outbreak in northwestern Democratic Republic of the Congo (DRC), up from eight last week. The World Health Organization (WHO) confirmed in an email today that there are 12 cases in Equateur province, which includes 9 confirmed and 3 probable infections. Five deaths have been reported.
Implementation of behavioral "nudges" targeting non–guideline-concordant antibiotic prescribing helped reduce inappropriate prescribing for respiratory tract infections at three California urgent care centers (UCCs), researchers reported last week in Open Forum Infectious Diseases.
A study yesterday in the Annals of Internal Medicine of more than 2,000 Europeans diagnosed as having mild to moderate COVID-19 shows that 87% reported loss of smell, and 56% reported taste dysfunction. The study suggests olfactory symptoms and taste disorders may be a common feature of COVID-19 infection.
Four countries in the Middle East and Africa reported a total of nine new cases this week, according to the latest update from the Global Polio Eradication Initiative (GPEI).
US drug maker Pfizer Inc. and Germany biopharmaceutical company BioNTech announced today that the first US participants in a clinical trial for a novel coronavirus vaccine have begun receiving doses.
Public campaigns that use "fear-based" messaging to reduce antibiotic use and antimicrobial resistance (AMR) may be more effective if they also contain messages that empower patients to self-manage without antibiotics, UK researchers reported in a study published today in BMC Medicine.
